Written Question · S5W-11309 · Session 5
what action it takes to ensure that people requiring access to continuous glucose monitoring (CGM) devices can do so, and what its positio…
The question
To ask the Scottish Government what action it takes to ensure that people requiring access to continuous glucose monitoring (CGM) devices can do so, and what its position is on rolling out the FreeStyle Libre System of CGMs.
The answer
I refer the member to the answer to question S5O-01194 on 29 June 2017 regarding continuous glucose monitoring (CGM) devices. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx.
CGM enables people to see their blood glucose levels 24 hours a day and will alert patients through an alarm/vibration if the sensor detects blood glucose values that exceed or will exceed the target zone set for their glucose levels, helping them to optimise glycaemic control. Flash glucose monitoring devices do not provide continuous real-time data but rather intermittent measurements which are accessed after the event and therefore cannot provide any alerts.
The Scottish Government notes the announcement by Abbott of the decision to include the Freestyle Libre flash glucose monitoring system on the England and Wales drug tariff. NHS Scotland has yet to receive official notification. Once received, NHS Scotland will follow the established due process for consideration of inclusion on the Scottish Drug Tariff.
CGM enables people to see their blood glucose levels 24 hours a day and will alert patients through an alarm/vibration if the sensor detects blood glucose values that exceed or will exceed the target zone set for their glucose levels, helping them to optimise glycaemic control. Flash glucose monitoring devices do not provide continuous real-time data but rather intermittent measurements which are accessed after the event and therefore cannot provide any alerts.
The Scottish Government notes the announcement by Abbott of the decision to include the Freestyle Libre flash glucose monitoring system on the England and Wales drug tariff. NHS Scotland has yet to receive official notification. Once received, NHS Scotland will follow the established due process for consideration of inclusion on the Scottish Drug Tariff.
In the Official Report
No contribution in the Official Report cites S5W-11309 by reference.